A noncoding RNA modulator potentiates phenylalanine metabolism in mice
The functional role of long noncoding RNAs (lncRNAs) in inherited metabolic disorders, including phenylketonuria (PKU), is unknown. Here, we demonstrate that the mouse lncRNA and human associate with phenylalanine hydroxylase (PAH). -knockout mice exhibited excessive blood phenylalanine (Phe), musty...
Saved in:
Published in | Science (American Association for the Advancement of Science) Vol. 373; no. 6555; pp. 662 - 673 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The American Association for the Advancement of Science
06.08.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The functional role of long noncoding RNAs (lncRNAs) in inherited metabolic disorders, including phenylketonuria (PKU), is unknown. Here, we demonstrate that the mouse lncRNA
and human
associate with phenylalanine hydroxylase (PAH).
-knockout mice exhibited excessive blood phenylalanine (Phe), musty odor, hypopigmentation, growth retardation, and progressive neurological symptoms including seizures, which faithfully models human PKU.
depletion led to reduced PAH enzymatic activities in human induced pluripotent stem cell-differentiated hepatocytes. Mechanistically,
modulated the enzymatic activities of PAH by facilitating PAH-substrate and PAH-cofactor interactions. To develop a therapeutic strategy for restoring liver lncRNAs, we designed GalNAc-tagged lncRNA mimics that exhibit liver enrichment. Treatment with GalNAc-
mimics reduced excessive Phe in
and
mice and improved the Phe tolerance of these mice. |
---|---|
Bibliography: | Author contributions: L.Q.Y. and C.R.L. conceived the project and designed the experiments. Y.J.L. executed the primary studies. Y.J.L. developed genetic mouse models and related experiments with assistance of Q.S.H. and Y.H.Z. T.K.N., X.Z., L.C.L., H.H., L.L. and J.M.X. Z.T. and S.Z. performed the proteomics and modeling studies. J.Y., Y.Q.Y., Z.Z. and L.H. performed bioinformatics analysis. The histological staining and corresponding analysis were performed by Y.J.L. with assistance of K.L. D.H. executed mass spectrometry analysis. CLIP assay were performed by L.Q.Y., S.S.C., Y.H.P. and P.H.G. Metabolic profiling were performed and analyzed by N. P. and analyzed by C.C. Clinical specimens were ascertained and processed by F.N., J.L.G., F.F. with assistance of M.S. an L.Q.Y. Protein purification were performed by Y.J.L. with assistance of Y.C.L. and K.L.T., S.Z. M.C.H., G.A.C., M.S., A.C.M., N.B., V.R.S. and F.F. contributed to experimental design and data interpretation. S.D.E. assisted with manuscript drafting. L.Q.Y. and C.R.L. wrote the manuscript. Contribute equally |
ISSN: | 0036-8075 1095-9203 |
DOI: | 10.1126/science.aba4991 |